IDR 1060.0
(-2.3%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 156.01 Billion IDR | -35.82% |
2022 | 243.09 Billion IDR | -38.01% |
2021 | 392.15 Billion IDR | 172.28% |
2020 | 144.02 Billion IDR | 63.66% |
2019 | 88 Billion IDR | 7.44% |
2018 | 81.9 Billion IDR | 74.05% |
2017 | 47.05 Billion IDR | 140.23% |
2016 | 19.58 Billion IDR | 88.26% |
2015 | 10.4 Billion IDR | 94.34% |
2014 | 5.35 Billion IDR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | 73.92 Billion IDR | -1.4% |
2024 Q2 | 74.97 Billion IDR | 3.8% |
2024 Q1 | 72.22 Billion IDR | 25.57% |
2023 Q3 | 34.02 Billion IDR | 0.17% |
2023 FY | 156.01 Billion IDR | -35.82% |
2023 Q1 | 30.5 Billion IDR | 19.61% |
2023 Q2 | 33.96 Billion IDR | 11.36% |
2023 Q4 | 57.52 Billion IDR | 69.06% |
2022 Q2 | 79.97 Billion IDR | -36.07% |
2022 Q3 | 12.5 Billion IDR | -84.37% |
2022 Q4 | 25.5 Billion IDR | 103.95% |
2022 FY | 243.09 Billion IDR | -38.01% |
2022 Q1 | 125.11 Billion IDR | 7.84% |
2021 Q3 | 120.93 Billion IDR | 40.85% |
2021 FY | 392.15 Billion IDR | 172.28% |
2021 Q4 | 116.01 Billion IDR | -4.07% |
2021 Q1 | 69.31 Billion IDR | 28.22% |
2021 Q2 | 85.86 Billion IDR | 23.87% |
2020 Q1 | 23.35 Billion IDR | 3.78% |
2020 Q2 | 28.35 Billion IDR | 21.42% |
2020 FY | 144.02 Billion IDR | 63.66% |
2020 Q4 | 54.05 Billion IDR | 41.33% |
2020 Q3 | 38.25 Billion IDR | 34.88% |
2019 Q4 | 22.5 Billion IDR | 10.41% |
2019 FY | 88 Billion IDR | 7.44% |
2019 Q3 | 20.38 Billion IDR | -7.63% |
2019 Q2 | 22.06 Billion IDR | -4.25% |
2019 Q1 | 23.04 Billion IDR | -0.1% |
2018 Q3 | 22.3 Billion IDR | 20.68% |
2018 FY | 81.9 Billion IDR | 74.05% |
2018 Q4 | 23.07 Billion IDR | 3.43% |
2018 Q1 | 18.04 Billion IDR | 21.9% |
2018 Q2 | 18.48 Billion IDR | 2.44% |
2017 FY | 47.05 Billion IDR | 140.23% |
2017 Q1 | 5.81 Billion IDR | 30.28% |
2017 Q2 | 9.99 Billion IDR | 71.83% |
2017 Q3 | 16.44 Billion IDR | 64.61% |
2017 Q4 | 14.8 Billion IDR | -10.01% |
2016 Q3 | 9.24 Billion IDR | 214.64% |
2016 FY | 19.58 Billion IDR | 88.26% |
2016 Q2 | 2.93 Billion IDR | -0.0% |
2016 Q1 | 2.93 Billion IDR | 0.0% |
2016 Q4 | 4.46 Billion IDR | -51.73% |
2015 FY | 10.4 Billion IDR | 94.34% |
2014 FY | 5.35 Billion IDR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
PT Hetzer Medical Indonesia Tbk | -3.57 Billion IDR | 4469.604% |
PT Jayamas Medica Industri Tbk | 259.35 Billion IDR | 39.846% |
Maja Agung Latexindo Tbk. | 5.46 Billion IDR | -2753.061% |